SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 28.95
(-9.95%)
TWD 28.95
(-9.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 378.36 Million TWD | -13.35% |
| 2022 | 436.64 Million TWD | -47.04% |
| 2021 | 824.43 Million TWD | -9.8% |
| 2020 | 913.99 Million TWD | 19.65% |
| 2019 | 763.87 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 349.36 Million TWD | -7.11% |
| 2024 Q1 | 376.11 Million TWD | -0.59% |
| 2023 Q4 | 378.36 Million TWD | 35.27% |
| 2023 FY | 378.36 Million TWD | -13.35% |
| 2023 Q3 | 279.71 Million TWD | -25.6% |
| 2023 Q2 | 375.96 Million TWD | -6.62% |
| 2023 Q1 | 402.6 Million TWD | -7.8% |
| 2022 FY | 436.64 Million TWD | -47.04% |
| 2022 Q4 | 436.64 Million TWD | 0.0% |
| 2021 FY | 824.43 Million TWD | -9.8% |
| 2020 FY | 913.99 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -195.487% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 86.957% |
| Level Biotechnology Inc. | 822.67 Million TWD | 54.008% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 43.08% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 31.05% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 90.283% |
| GlycoNex Incorporation | 1.55 Billion TWD | 75.634% |
| VBI | 452.1 Million TWD | 16.31% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 67.83% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 49.455% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 66.63% |
| Visgeneer Inc. | 397.17 Million TWD | 4.737% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 89.965% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 82.475% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 57.155% |
| Neith Corporation | 192.15 Million TWD | -96.907% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 93.79% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -414.372% |
| Enimmune corporation | 604.82 Million TWD | 37.443% |
| TaiRx, Inc. | 833.74 Million TWD | 54.619% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 87.74% |
| EirGenix Inc. | 11.16 Billion TWD | 96.61% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 33.984% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 77.904% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 89.48% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 63.982% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -25.688% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -42.963% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 14.241% |
| RBC Bioscience Corporation | 753.79 Million TWD | 49.805% |
| BiOptic Inc. | 613.77 Million TWD | 38.355% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 78.728% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 67.375% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 41.325% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 87.819% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -155.764% |
| NaviFUS Corp. | 490.53 Million TWD | 22.867% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 69.131% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 72.248% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 28.496% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 67.422% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 77.156% |
| AP Biosciences Inc | 890.75 Million TWD | 57.523% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 95.563% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -16.725% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 71.629% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 86.044% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.537% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 7.775% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 4.659% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 81.774% |
| TCI GENE Inc. | 1.16 Billion TWD | 67.549% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -28.441% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 72.247% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 59.824% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 45.828% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 90.431% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 90.102% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 69.235% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 93.248% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 64.373% |
| Acepodia, Inc. | 6.81 Billion TWD | 94.451% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 90.112% |